Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

FDA Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria

Saturday, July 15, 2017

Allena Pharmaceuticals Inc a specialty biopharmaceutical company dedicated to bringing first in class specific nonabsorbed oral protein therapeutics to patients with serious renal urologic and orphan diseases announced today that the US Food and Drug...

FDA Grants Fast Track Designation to VT-1598 for Treatment of Valley Fever

Friday, July 14, 2017

Viamet Pharmaceuticals Inc today announced that the US Food and Drug Administration FDA has granted Fast Track designation to VT a novel oral agent for the treatment of coccidioidomycosis also known as Valley Fever Valley Fever is an invasive fungal...

ShangPharma Innovation and the University of California San Francisco Announce Strategic Research Collaboration

Friday, July 14, 2017

In a new collaboration ShangPharma Innovation Inc SPII is providing funding and other support to scientists at UC San Francisco UCSF to accelerate the development of promising life science inventions The partnership helps advance a major new initi...

Sanofi to acquire Protein Sciences

Thursday, July 13, 2017

Sanofi announced it will acquire Protein Sciences a privately held vaccines biotechnology company based in Meriden Connecticut in the United States Under the terms of the agreement Sanofi will make an upfront payment of million and pay up to millio...

BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada)

Thursday, July 13, 2017

BioDelivery Sciences International Inc a specialty pharmaceutical company with a focus in pain management and addiction medicine and Purdue Pharma Canada announce that they have signed an exclusive agreement for the licensing distribution marketing a...

Abzena and OBI Pharma Sign ThioBridge™ Licence Agreement

Wednesday, July 12, 2017

Abzena plc the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products has signed a licensing agreement and a master services and clinical supply agreement with OBI Pharma a Taiw...

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center

Wednesday, July 12, 2017

CURE Pharmaceutical a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company and Therapix Biosciences a specialty clinicalstage pharmaceutical company dedicated to the development of cannabinoidbased d...

Race Oncology Limited Joint Venture With TargImmune

Tuesday, July 11, 2017

Race Oncology Limited announced that it has executed a Letter of Intent with TargImmune Therapeutics AG Basel Switzerland to enter into a joint venture between the two companies The joint venture to be called Race Immunotherapeutics will focus on dev...

InMed Pharmaceuticals Signs R&D Agreement with ATERA

Tuesday, July 11, 2017

InMed Pharmaceuticals Inc a biopharmaceutical company specializing in the research and development of novel cannabinoidbased drug therapies is pleased to announce it has entered into a research and development collaboration with ATERA SAS of France a...

Capricor Therapeutics Retains Full Rights to CAP-1002 as Janssen Biotech, Inc. Decides Not to Exercise Option

Monday, July 10, 2017

Capricor Therapeutics Inc announced that Janssen Biotech Inc Janssen has decided not to exercise its option to exclusively license Capricors lead candidate CAP allogeneic cardiospherederived cells for development and commercialization in the field of...